JP5735200B2 - 経口避妊薬の形での機能不全子宮出血の経口治療のためへの吉草酸エストラジオール又はエストラジオールとジエノゲストとの使用 - Google Patents

経口避妊薬の形での機能不全子宮出血の経口治療のためへの吉草酸エストラジオール又はエストラジオールとジエノゲストとの使用 Download PDF

Info

Publication number
JP5735200B2
JP5735200B2 JP2008534936A JP2008534936A JP5735200B2 JP 5735200 B2 JP5735200 B2 JP 5735200B2 JP 2008534936 A JP2008534936 A JP 2008534936A JP 2008534936 A JP2008534936 A JP 2008534936A JP 5735200 B2 JP5735200 B2 JP 5735200B2
Authority
JP
Japan
Prior art keywords
estradiol
dienogest
uterine bleeding
oral
bleeding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2008534936A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009511526A (ja
Inventor
ツォイン，スーザン
ブドゥ，ポル
エンドリカト，ヤン
セッシ，アンジェロ
ツィンマーマン，ホルガー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Intellectual Property GmbH
Original Assignee
Bayer Intellectual Property GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35811580&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP5735200(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Intellectual Property GmbH filed Critical Bayer Intellectual Property GmbH
Publication of JP2009511526A publication Critical patent/JP2009511526A/ja
Application granted granted Critical
Publication of JP5735200B2 publication Critical patent/JP5735200B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
JP2008534936A 2005-10-13 2006-10-12 経口避妊薬の形での機能不全子宮出血の経口治療のためへの吉草酸エストラジオール又はエストラジオールとジエノゲストとの使用 Active JP5735200B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05022324A EP1787649B1 (de) 2005-10-13 2005-10-13 Verwendung von Estradiolvalerat in Kombination mit Dienogest zur oralen Therapie der dysfunktionellen uterinen Blutung in Einheit mit einer oralen Kontrazeption
EP05022324.7 2005-10-13
PCT/EP2006/009867 WO2007042296A1 (de) 2005-10-13 2006-10-12 Verwendung von estradiolvalerat oder estradiol in kombination mit dienogest zur oralen therapie der dysfunktionellen uterinen blutung in einheit mit einer oralen kontrazeption

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012253067A Division JP2013047269A (ja) 2005-10-13 2012-11-19 経口避妊薬の形での機能不全子宮出血の経口治療のためへの吉草酸エストラジオール又はエストラジオールとジエノゲストとの使用

Publications (2)

Publication Number Publication Date
JP2009511526A JP2009511526A (ja) 2009-03-19
JP5735200B2 true JP5735200B2 (ja) 2015-06-17

Family

ID=35811580

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008534936A Active JP5735200B2 (ja) 2005-10-13 2006-10-12 経口避妊薬の形での機能不全子宮出血の経口治療のためへの吉草酸エストラジオール又はエストラジオールとジエノゲストとの使用
JP2012253067A Pending JP2013047269A (ja) 2005-10-13 2012-11-19 経口避妊薬の形での機能不全子宮出血の経口治療のためへの吉草酸エストラジオール又はエストラジオールとジエノゲストとの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012253067A Pending JP2013047269A (ja) 2005-10-13 2012-11-19 経口避妊薬の形での機能不全子宮出血の経口治療のためへの吉草酸エストラジオール又はエストラジオールとジエノゲストとの使用

Country Status (22)

Country Link
EP (2) EP1787649B1 (https=)
JP (2) JP5735200B2 (https=)
KR (2) KR101218872B1 (https=)
CN (1) CN101312733A (https=)
AR (1) AR056694A1 (https=)
AT (2) ATE424828T1 (https=)
CA (1) CA2623024C (https=)
CL (1) CL2011000283A1 (https=)
CY (2) CY1110321T1 (https=)
DE (2) DE502005006837D1 (https=)
DK (2) DK1787649T3 (https=)
DO (1) DOP2006000221A (https=)
ES (2) ES2322479T3 (https=)
HR (1) HRP20090256T1 (https=)
ME (1) ME01056B (https=)
PE (2) PE20100090A1 (https=)
PL (2) PL1787649T3 (https=)
PT (2) PT1787649E (https=)
SI (2) SI1787649T1 (https=)
TW (2) TWI328453B (https=)
UY (1) UY29861A1 (https=)
WO (1) WO2007042296A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
SI1787649T1 (sl) * 2005-10-13 2009-08-31 Bayer Schering Pharma Ag Uporaba estradiolvalerata v kombinaciji z dienogestom za oralno terapijo disfunkcionalne maternične krvavitve skupaj z oralno kontracepcijo
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4429374C1 (de) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
DE19540253C2 (de) * 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
ATE249222T1 (de) * 1996-07-26 2003-09-15 Wyeth Corp Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten
US6251956B1 (en) 1998-08-20 2001-06-26 Ortho Pharmaceutical Corporation Combination progestin oral contraceptive regimen
EP1462106A1 (en) * 2003-03-28 2004-09-29 Pantarhei Bioscience B.V. Pharmaceutical compositions and kits comprising 17-beta-estradiol and a progesteron for the treatment of gynecological disorders
DE102004019743B4 (de) * 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
SI1787649T1 (sl) * 2005-10-13 2009-08-31 Bayer Schering Pharma Ag Uporaba estradiolvalerata v kombinaciji z dienogestom za oralno terapijo disfunkcionalne maternične krvavitve skupaj z oralno kontracepcijo

Also Published As

Publication number Publication date
CA2623024A1 (en) 2007-04-19
EP1933843A1 (de) 2008-06-25
ES2322479T3 (es) 2009-06-22
WO2007042296A1 (de) 2007-04-19
ATE424828T1 (de) 2009-03-15
JP2009511526A (ja) 2009-03-19
SI1933843T1 (sl) 2011-06-30
PT1787649E (pt) 2009-05-08
EP1787649A1 (de) 2007-05-23
ES2360302T3 (es) 2011-06-02
CL2011000283A1 (es) 2011-07-08
PT1933843E (pt) 2011-04-29
KR20080065651A (ko) 2008-07-14
HRP20090256T1 (en) 2009-06-30
AR056694A1 (es) 2007-10-17
DE502005006837D1 (de) 2009-04-23
PL1933843T3 (pl) 2011-06-30
SI1787649T1 (sl) 2009-08-31
CA2623024C (en) 2012-03-06
TW200731977A (en) 2007-09-01
DOP2006000221A (es) 2007-08-31
PE20100090A1 (es) 2010-03-12
CN101312733A (zh) 2008-11-26
DK1787649T3 (da) 2009-06-02
TWI328453B (en) 2010-08-11
UY29861A1 (es) 2007-05-31
DE502006008853D1 (de) 2011-03-17
EP1787649B1 (de) 2009-03-11
TW200829255A (en) 2008-07-16
ATE497387T1 (de) 2011-02-15
CY1111406T1 (el) 2015-08-05
KR20100082389A (ko) 2010-07-16
PL1787649T3 (pl) 2009-08-31
KR101218872B1 (ko) 2013-01-07
CY1110321T1 (el) 2015-01-14
DK1933843T3 (da) 2011-04-18
PE20070555A1 (es) 2007-07-12
JP2013047269A (ja) 2013-03-07
ME01056B (me) 2012-10-20
EP1933843B1 (de) 2011-02-02

Similar Documents

Publication Publication Date Title
CN100408040C (zh) 三阶段口服避孕药
JP7177313B2 (ja) 避妊用組成物および避妊方法
Ahrendt et al. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel
ES2202498T3 (es) Estuche para la contracepcion en mamiferos hembras, que consta de una combinacion de un agente gestageno y un agente estrogeno.
FI117850B (fi) Progesteroniantagonisteja lääkeaineiden valmistamiseksi, jotka on tarkoitettu kohdun toimintahäiriöistä johtuvien verenvuotojen hoitamiseksi
Golobof et al. The current status of oral contraceptives: progress and recent innovations
US20050113350A1 (en) Extended use combination comprising estrogens and progestins
JP2007512291A (ja) ２種のエストロゲン及び／又はプロゲスチン組成物を含んで成る、２１〜２８日よりも長い期間にわたっての連続ホルモン処理のための医薬製剤
KR20150058555A (ko) 연장된 호르몬성 피임제 투약법에서 파탄성 출혈의 관리
LaGuardia et al. Suppression of estrogen-withdrawal headache with extended transdermal contraception
JP2013047269A (ja) 経口避妊薬の形での機能不全子宮出血の経口治療のためへの吉草酸エストラジオール又はエストラジオールとジエノゲストとの使用
US20100190757A1 (en) Combination preparation for oral contreaception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
TWI351960B (en) Multiphase product for contraception based on a na
JP2013047269A5 (https=)
Qureshi et al. Review of newer contraceptive agents
BE1027858B1 (fr) Composition pharmaceutique pour la contraception chez la femme
US20070088011A1 (en) Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
ES2382459T3 (es) Utilización de valerato de estradiol, en combinación con dienogest para la terapia por vía oral de la hemorragia uterina disfuncional, en unión con una contracepción oral
US20070088010A1 (en) Method of making a single-stage pharmaceutical preparation for oral therapy of dysfunctional uterine bleeding, containing ethinyl estradiol and dienogest
HK1124267A (en) Use of estradiol valerate or estradiol combined with dienogest for the oral therapy of dysfunctional uterine bleeding in the form of oral contraceptives
CN1172675C (zh) 黄体酮拮抗剂用于制备治疗机能障碍性子宫出血的药物
JP2008527018A (ja) 避妊用医薬製剤
RS50849B (sr) Upotreba estradiolvalerata i dienogesta za oralno lečenje disfunkcionalnog uterinog krvarenja u kontracepcijskom metodu
Tsybina et al. Availability of novel contraceptive methods in Canada
JP2009511512A (ja) 機能不全子宮出血の経口治療のための単相医薬製品の製造方法

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111004

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20111228

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120111

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120404

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120717

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20130724

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141020

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20141023

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20141111

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20141111

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150416

R150 Certificate of patent or registration of utility model

Ref document number: 5735200

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250